Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-02-15

Clinical Trial Update: 17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa [NA]

View source ↗

Summary

This clinical trial update concerns the use of 17-alpha-hydroxyprogesterone caproate in pregnant women with placenta previa; the status of the trial is not spec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 17-alpha-hydroxyprogesterone caproate (17-alpha-hydroxyprogesterone caproate)

Snippet

Sponsor: Aswan University Hospital | Conditions: Placenta Previa | NA | Status: UNKNOWN